Sana'a: On May 8, World Thalassemia Day is observed globally, yet for Yemeni children afflicted by this hereditary disease, the occasion is marked by increased suffering and pain. Their daily lives involve a relentless struggle for essential medical care amidst a backdrop of ongoing conflict and blockades.
According to Yemen News Agency, the dire situation is exacerbated by the US-Saudi-UAE coalition's actions, which have severely restricted access to vital medicines and medical supplies. This has led to inflated prices and diminished purchasing power, making it increasingly difficult for patients to obtain necessary treatments, including those requiring specific transportation conditions.
Dr. Anis Al-Asbahi, spokesperson for the Ministry of Health and Environment, highlighted the plight of over 40,000 patients with thalassemia and hereditary hemolytic anemia. These individuals face life-threatening situations due to medicine shortages and restrictions on entry through Sana'a International Airport, particularly concerning iron-chelation drugs and related medical solutions. Al-Asbahi reported that 684 patients have died out of the 8,430 undergoing treatment at the Yemeni Thalassemia Patients Association's center.
He emphasized the need for greater community awareness regarding premarital medical screening to prevent the transmission of these genetic disorders to future generations. Al-Asbahi held the aggressor countries responsible for the deteriorating health situation, rising death toll, and lack of essential medicines for thalassemia patients.
Thalassemia and hereditary hemolytic anemia, chronic hereditary illnesses, are characterized by persistent anemia that begins shortly after birth and continues for life. These conditions necessitate regular blood transfusions and can result in severe complications, including spleen and liver enlargement, bone deformities, hormonal changes, and organ damage due to iron overload.
The Yemeni Association for Thalassemia and Genetic Blood Disorders previously warned of worsening conditions for more than 40,000 patients, mostly children, due to the blockade and medicine shortages since early 2025. The association reported that the number of registered patients in Sana'a and Al Hodeidah exceeded 13,000 by February 2026, with the Sana'a treatment center seeing an average of 120 patients daily.
The absence of iron-chelation medicines since early 2025 poses a severe threat to thousands of children requiring regular blood transfusions. The association urged authorities and international organizations to provide essential iron-removal medicines and safe blood transfusion services, highlighting the blockade as a national catastrophe endangering the future of Yemeni childhood.
Commemorating World Thalassemia Day aims to increase societal awareness and support for patients. However, the condition of thalassemia patients in Yemen remains critical, with an urgent need for medicines and blood. The blockade has obstructed medicine shipments, increased import costs, and led to the collapse of the healthcare sector.
The situation for Yemeni children with thalassemia is precarious. Their survival depends on immediate action to lift the medical blockade, ensuring a consistent supply of medical necessities, and supporting families burdened by economic challenges. Each delay in addressing these issues risks losing another child, and silence equates to complicity in their suffering. The world must heed the call of Yemeni children seeking life-saving treatments.